Found 38 matching trials
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma PHASE2 The primary objectives of the study are to evaluate the safety and the effi...
Show More Learn More & Join Trial
A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers PHASE1 To evaluate the safety, tolerability, PK and preliminary PD of SSS11 for in...
Show More Location
The Fifth Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Rasburicase (Fasturtec) Registration Trial PHASE3 Primary:
To compare the efficacy of Rasburicase versus allopurinol in cont...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout PHASE2 The purpose of this study is to determine whether PEG-uricase (a chemically...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia PHASE4 Primary Objective:
To evaluate safety of rasburicase in pediatric patients...
Show More Location
investigational site CHINA
Learn More & Join Trial
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant PHASE1 RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome PHASE3 This is a randomized, multi-center, open-label, parallel group study with t...
Show More Location
Alta Bates Comprehensive Cancer Center
Learn More & Join Trial
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients N/A This is a multi-center trial for rasburicase in children at high risk of tu...
Show More Location
Stanford University
Learn More & Join Trial
A Study of IN026 in Participants With Refractory Gout PHASE1 The goal of this clinical study is to learn if IN026 Injection is safe and ...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy PHASE4 This is an open-label, multi-center study with 2 arms. The primary objectiv...
Show More Location
Alta Bates Comprehensive Cancer Center
Learn More & Join Trial